Scholars Central

ArticlePublished 29 Aug 2024

Patient-Reported Outcomes in Biologic Therapy for Rheumatoid Arthritis

Authors: Mahi Zaman

International Journal of Clinical Rheumatology

Volume 19 · Issue 8 · Pages 202–204

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patient-reported outcomes (PROs) are crucial in evaluating the effectiveness of treatments for rheumatoid arthritis (RA), especially with the advent of biologic therapies. These outcomes provide insights into the patient's perspective on their health status, treatment efficacy, and quality of life. This article reviews the role of PROs in assessing the impact of biologic therapies on RA, examining key dimensions such as pain, function, fatigue, and overall health-related quality of life. By analyzing current literature and clinical trials, this review highlights the importance of integrating PROs into routine clinical practice to ensure patient-centered care and optimize treatment strategies.

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Clinical Rheumatology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Rheumatology
  • SubjectRheumatology
  • BylineArticles whose byline prints “Mahi Zaman”